 |
|
|
|
|
|
|
|
|
|
|
|
Home
|
|
|
|
|
|
|
|
|
|
|
Actelion is a global, independent biopharmaceutical
company discovering,
developing and
marketing innovative drugs for high unmet medical needs.
|
Actelion worldwide
|
| Actelion has subsidaries in 23 countries, covering all major pharmaceutical markets worldwide
|
|
|
|
|
News at a glance
22 Apr 2008 · Actelion announces first quarter 2008 financial results
|
|
|
21 Apr 2008 · Actelion and Nippon Shinyaku enter into a license agreement on novel PAH compound
|
|
|
11 Apr 2008 · Annual General Meeting of Shareholders in Basel, Switzerland
|
|
|
29 Feb 2008 · Actelion and Nippon Shinyaku to collaborate on novel PAH compound
|
|
|
21 Feb 2008 · Actelion announces Full Year 2007 financial results
|
|
|
Events at a glance
05 May 2008 · 33rd Deutsche Bank Annual Health Care Conference |
Actelion presents at the 33rd Deutsche Bank Unplugged Annual Health Care Conference in Boston, US. The presentation is scheduled for Mon, 5 May 2008 at 15:20 hrs Boston EDT (21:20 Basel, CEST/ 20:20 UK, BST). The webcast replay will be available approximately 1 hour after the webcast presentation ends and is accessible for 3 months.
30 Apr 2008 · Morgan Stanley 2008 Global Healthcare Unplugged Conference |
Actelion presents at the Morgan Stanley 2008 Global Healthcare Unplugged Conference in Miami, US. The presentation is scheduled for Wed, 30 April 2008 at 14:20 hrs Miami EDT (20:20 Basel, CEST/ 19:20 UK, BST). The webcast replay will be available approximately 1 hour after the webcast presentation ends and is accessible for 3 months.
|
|
|
|
|
|
Date |
09/05/2008
|
Time |
17:32 CET |
Last |
CHF 53.70 |
Change |
-0.75(-1.38%) |
Volume |
467,559 |
Market Cap. |
CHF 6.68 bn |
|
|
 |
AGM 2008
|
|
 |
Annual Report 2007
|
|
 |
Financial Information
For Actelion's full financial statements, please click "more"
|
|
 |
Clinical Trials Database
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
